Novavax COVID-19 Vaccine Demonstrates 90% Overall Ef...93% efficacy against predominantly circulating Variants of Concern and Variants of Interest
91% efficacy in high-risk populations
100% efficacy against variants "not considered Variants of Concern/Interest"
All COVID-19 hospitalizations/death occurred in the placebo group